Joel Greenblatt profiled in Barron's
Money and Finance

Joel Greenblatt profiled in Barron's


Link to: Writing a Bigger Book
In 2009, at the behest of investors, their Gotham Asset Management firm put out the welcome mat again, this time with a far more diversified approach. The current strategy is, on the surface, pretty simple. Buy more than 300 high-quality names trading at cheap prices, and short more than 300 stocks on the other end of that spectrum. The stock that ranks first on these attributes gets the largest weighting in the portfolio, while the second-best stock gets the No. 2 weighting, and so on. 
"That's quite a bit different from the six to eight holdings we had once upon a time," says Greenblatt, 56. At the same time the original, highly focused strategy had limited capacity, it also came with extreme volatility. "Rob and I would wake up some days and lose 15% or 20% of our net worth," he adds. "Now it's more like 15 or 20 basis points." (A basis point is 1/100th of a percentage point.)
.................

Related books:

The Little Book That Still Beats the Market

You Can Be a Stock Market Genius





- A Conversation Between Joel Greenblatt And Howard Marks
A great quote from Greenblatt during the conversation, which reminded me of the Kelly Criterion: "My largest positions are not the ones I think I'm going to make the most money from. My largest positions are the ones I don't think I'm going...

- Links
A Dozen Things Learned from Joel Greenblatt about Value Investing (LINK) Related books: The Little Book That Still Beats the Market and You Can Be a Stock Market Genius Related video: Joel Greenblatt on WealthTrackMacau High Rollers Leaving For Philippines...

- Joel Greenblatt Says Apple, Google Are ‘bargains’ (video)
Thanks to Lincoln for passing this along. May 9 (Bloomberg) -- Joel Greenblatt, managing partner at Gotham Asset Management, talks about investment strategy and some of his stock picks, including Apple Inc. Greenblatt also discusses some of his stock...

- Glaxosmithkline - Stout Yield Worth The Risks?
GlaxoSmithKline is the second stock that I added to the Wide Moat Dividend (WMD) portfolio. The positives are pretty clear - a 5.6% yield really stands out in this yield parched world. All the better when it comes from a defensive company like Glaxo and...

- High Yield Reads - 7/19/14
Summary of recent stories of interest, sometimes enduring, to investors: Two good pieces in Barron's this week first up - Quite Contrary. I am always struck by virtually every fund manager and finance pro that I see interviewed characterizes themselves...



Money and Finance








.